TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Olink Proteomics AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,473,511
|
1,357,752
|
780,087 |
| Financial expenses |
48,814
|
4,735
|
7 |
| Earnings before taxes |
-90,059
|
4,584
|
-85,897 |
| EBITDA |
-14,957
|
24,396
|
-76,843 |
| Total assets |
1,875,073
|
1,256,042
|
1,020,734 |
| Current assets |
1,067,080
|
908,758
|
742,504 |
| Current liabilities |
283,799
|
878,179
|
647,157 |
| Equity capital |
1,591,274
|
377,863
|
373,577 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
362
|
289
|
183 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
84.9%
|
30.1%
|
36.6% |
| Turnover per employee |
4,070
|
4,698
|
4,263 |
| Profit as a percentage of turnover |
-6.1%
|
0.3%
|
-11.0% |
| Return on assets (ROA) |
-2.2%
|
0.7%
|
-8.4% |
| Current ratio |
376.0%
|
103.5%
|
114.7% |
| Return on equity (ROE) |
-5.7%
|
1.2%
|
-23.0% |
| Change turnover |
115,759
|
577,665
|
288,272 |
| Change turnover % |
9%
|
74%
|
59% |
| Chg. No. of employees |
73
|
106
|
53 |
| Chg. No. of employees % |
25%
|
58%
|
41% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.